Retinal angiomatous proliferation: Clinical characteristics and treatment options

Optometry

Volumn 75, Issue 9, 2004, Pages 577-588

  Hunter, Megan A ^a   Dunbar, Mark T ^b   Rosenfeld, Phillip J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; Choroidal neovascularization; Fluorescein angiography; Indocyanine green angiography; Intraretinal neovascularization; Optical coherence tomography; Pigment epithelial detachment

Indexed keywords

TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; BLEEDING; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; RETINA EDEMA; RETINA HEMORRHAGE; RETINA MACULA DEGENERATION; RETINAL ANGIOMATOUS PROLIFERATION; VISUAL ACUITY;

EID: 12344338948     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1839(04)70190-6     Document Type: Article

References (30)

1. Slakter JS, Uannuzzi LA, Schneider U, et al. Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 2000;107:742-54.
2. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019-29.
3. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416-34.
4. Yannuzzi LA, Hope-Ross M, Slakter JA et al. Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 1994;14:99-113.
5. Wells JA, Murthy R, Chibber R, et al. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularization. Br J Ophthalmol 1996;80:363-6.
6. Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996;37:855-68.
7. Hartnett ME, Weiter JJ, Gardts A, et al. Classification of retinal pigment epithelial detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 1992;230:11-9.
8. Kuhn D, Meunier I, Soubrane G, et al. Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelial detachments. Arch Ophthalmol 1995;113:1392-8.
9. Gass JD. Occult retinal choroidal anastomosis. First Annual Robert Haimovici Memorial Lecture June 19, 2003; Bascom Palmer Eye Institute.
10. Macular Photocoagulation Study Group. Argon laser photocoagulation for age-related macular degeneration. Arch Ophthalmol 1982;100:912-8.
11. Fernandes LH, Freund KB, Yannuzzi LA, et al. The nature of focal areas of hyperfluorescence or 'hot spots' imaged with indocyanine green angiography. Retina 2002;22:557-68.
12. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of occult choroidal neovascularization. Ophthalmology 1994;101:1727-35.
13. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102:217-29.
14. Giovannini A, Amato GP, Mariotti C, et al. OCT imaging of choroidal neovascularization and its role in the determination of patients' eligibility for surgery. Br J Ophthalmol 1999;83:438-42.
15. Hrynchak P, Simpson T. Optical coherence tomography: an introduction to the technique and its use. Optom Vis Sci 2000;77:347-56.
16. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1. Arch Ophthalmol 1999;117:1329-45.
17. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001;119:198-207.
18. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes - TAP report 3. Arch Ophthalmol 2002;120:1443-54.
19. Verteportin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in Photodynamic Therapy report 2. Am J Ophthalmol 2001;131:541-60.
20. Pece A, Introini U, Bottoni F, et al. Acute retinal pigment epithelial tear after photodynamic therapy. Retina 2001;21(6):661-5.
21. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-7.
22. Jonas JB, Kreissig I, Sofker A, et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003,121:57-61.
23. Benhamou N, Massin P, Haouchine B, et al. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 2003;135:246-9.
24. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefe's Arch Clin Exp Ophthalmol 2002;240:782-3.
25. Danis RP, Bingaman DP, Yang Y, et al. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 1996;103:2099-104.
26. Penfold PL, Wen L, Madigan MC, et al. Triamcinolene acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clin Exp Immunol 2000;121:458-65.
27. Folkman J, Ingber D. Angiostatic steroids: method of discovery and mechanism of action. Ann Surg 1987;206:374-82.
28. Danis RP, Ciulla TA, Pratt LA, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-50.
29. Lopez PF, Sippy BD, Lambert HM, et al. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996;37:855-68.
30. The Eyetech Study Group. Preclinical and phase 1a clinical evaluation of an anti-VEGF pegylated adtamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 2002;22:143-52.